Dr. Glorioso, III, PhD, is world-renowned for his work on the molecular and genetic aspects of the herpes simplex virus and how to better engineer this organism as a vector for transporting therapeutic genes. Dr. Glorioso’s role as an international leader in the field of gene therapy also is recognized by his positions as founder and former president of the American Society of Gene Therapy, U.S. editor of Gene Therapy, and editorial board member of Molecular Therapy.
Dr. Glorioso received his bachelor’s degree and doctorate from Louisiana State University before joining the University of Michigan Medical School in the late 1970s. There, he attained the rank of professor and assistant dean for research and graduate studies. In 1989, he joined the University of Pittsburgh, School of Medicine where he served as Professor and Chair of the Department of Molecular Genetics and Biochemistryand the McEllroy Professorship in Biochemistry until 2009. He is currently a professor of Microbiology and Molecular Genetics. Dr. Glorioso continues his ground breaking work in the development of herpesviral vectors for the treatment of cancer, chronic pain and diseases of the central nervous system.